Chevron Left
Back to Drug Development

Learner Reviews & Feedback for Drug Development by University of California San Diego

4.6
428 ratings
85 reviews

About the Course

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Top reviews

HG

Oct 16, 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

MR

Jul 19, 2018

Information in the course is very practical. I come from basic biology background and now with this course I gained some real insights about how the clinical trails happen.

Filter by:

76 - 84 of 84 Reviews for Drug Development

By Adrián P F

Nov 12, 2018

The course is very informative, specially for people with no experience nor specialized formation in Clinical Trials. However, it is not very detailed nor demanding, so I doubt about its usefulness for someone with previous university formation in clinical research field.

By Damien V

Sep 17, 2018

good up to phase 2 (included). Phase 3 and after was less informative

By Eliza V

Jul 16, 2017

The overall material was good. However, the course was not structured as an online course, rather an online posting of in class lectures. This made it difficult to hear the questions of the students as the questions were not repeated by the lecturer and therefore we received an answer to a question we didn't hear. Also, because of the lecture nature, a lot of information was missing from the slides as it was spoken information.

By Carolina S V

Dec 27, 2017

Weeks 1 and 2 are great, but the classes of week 3 need more organization.

By Krithika S K N

Sep 02, 2019

Was informative. The lectures could have been more structured and slides more detailed.

By Nikolai W

Sep 25, 2019

The name of the course should be something a la 'Clincal trials and drug admistration agencies'. It is not the development of a drug.

By Benoit E

Feb 21, 2019

A lot too much bla bla on the Phase iv part

By Arash Y

Mar 03, 2018

Presentation slides and sound quality is at its lowest.

By Yurshanva K

Sep 04, 2019

Compare to other courses like python for everybody, this lecture is too boring, all they did was, they kept on reading the slides